Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Scilex Holding Co. (SCLX)

Scilex Holding Co. (SCLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 216,047
  • Shares Outstanding, K 166,190
  • Annual Sales, $ 46,740 K
  • Annual Income, $ -114,330 K
  • 60-Month Beta 0.68
  • Price/Sales 4.76
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade SCLX with:

Options Overview Details

View History
  • Implied Volatility 61.29% ( -21.06%)
  • Historical Volatility 158.64%
  • IV Percentile 4%
  • IV Rank 12.68%
  • IV High 373.13% on 12/07/23
  • IV Low 16.01% on 03/13/24
  • Put/Call Vol Ratio 0.05
  • Today's Volume 102
  • Volume Avg (30-Day) 205
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 6,071
  • Open Int (30-Day) 5,894

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.14
  • Number of Estimates 3
  • High Estimate -0.10
  • Low Estimate -0.17
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +36.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2600 +5.56%
on 03/14/24
1.7000 -21.76%
on 03/28/24
+0.0100 (+0.76%)
since 03/12/24
3-Month
1.2301 +8.12%
on 03/12/24
2.6300 -49.43%
on 02/29/24
-0.4700 (-26.11%)
since 01/12/24
52-Week
0.9001 +47.76%
on 11/22/23
16.2000 -91.79%
on 04/13/23
-13.4700 (-91.01%)
since 04/12/23

Most Recent Stories

More News
Why Shares of Scilex Are Up Monday

An analyst at H.C. Wainwright initiated coverage on the stock.

SCLX : 1.3300 (+2.31%)
Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company

/PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento" or "Company"), a biopharmaceutical company dedicated to the development of life-saving...

SCLX : 1.3300 (+2.31%)
ORMP : 2.52 (-2.33%)
Why Shares of Scilex Are Dropping Monday

The company's shares are being dragged down by its soon-to-be-former parent company.

SCLX : 1.3300 (+2.31%)
Sorrento Announces Launch of Voluntary Offering to Dividend Short Holders with Deadline to Participate by July 27, 2023

/PRNewswire/ -- In connection with its ongoing chapter 11 case, Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento"), a biopharmaceutical company dedicated to...

SCLX : 1.3300 (+2.31%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Scilex Holding Company for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

SCLX : 1.3300 (+2.31%)
Sorrento Therapeutics, Inc.'s Bankruptcy Court Orders Brokerage Firms to Credit Dividended Scilex Stock to Customers' Accounts and Sorrento Advises Holders of Dividended Scilex Stock to Contact Brokerage Firms to Deliver the Stock to Individual Accounts

/PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to...

SCLX : 1.3300 (+2.31%)
Why Shares of Scilex Slumped This Week

A stock sale and confusion regarding its parent company are factors dragging down the stock.

SRNE : 0.3073 (-20.26%)
SRNEQ : 0.0300 (+3.45%)
SCLX : 1.3300 (+2.31%)
Sorrento Therapeutics, Inc.'s Bankruptcy Court Requires Brokerages to Provide Information Related to Scilex Common Stock

/PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to...

SCLX : 1.3300 (+2.31%)
Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case

/PRNewswire/ -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to...

SRNE : 0.3073 (-20.26%)
SCLX : 1.3300 (+2.31%)
Sorrento Therapeutics, Inc. Receives Court Approval for "First Day" Employee Wages and Cash Management Motions

/PRNewswire/ -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to...

SRNE : 0.3073 (-20.26%)
SCLX : 1.3300 (+2.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Scilex Holding Company is a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain. Scilex Holding Company, formerly known as Vickers Vantage Corp. I, is based in PALO ALTO, Calif.

See More

Key Turning Points

3rd Resistance Point 1.4050
2nd Resistance Point 1.3700
1st Resistance Point 1.3500
Last Price 1.3300
1st Support Level 1.2950
2nd Support Level 1.2600
3rd Support Level 1.2400

See More

52-Week High 16.2000
Fibonacci 61.8% 10.3554
Fibonacci 50% 8.5501
Fibonacci 38.2% 6.7447
Last Price 1.3300
52-Week Low 0.9001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar